ResearchMoz

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

GBI Research
Published Date » 2014-04-01
No. Of Pages » 121
   
 GBI Research’s report: Insulin Delivery Devices Market to 2019 examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. 
   
  Scope  
   
 
 
 The markets of 12 key...
Table of Content

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12

2 Executive Summary 14
2.1 Global Insulin Delivery Devices Market to see Significant Growth during the Forecast Period 14
2.2 New Entrants Act as Catalysts in Transformation from a Physician-Driven to Consumer-Driven Market 15
2.3 Large Players’ Market Shares Decline as New Entrants Introduce Consumer-Friendly Features in the US 16
2.4 Increasing Prevalence of Diabetes to Continue to Drive Growth in the Insulin Delivery Devices Market 18
2.5 Insulin Pumps Drive Growth in Developed Economies as Insulin Pens Drive Adoption in Emerging Economies 19
2.6 Collaborations Foster Innovation to Address Unmet Need in Artificial Pancreas Systems 21
2.7 Public Funding of Insulin Pumps will Provide Long-Term Economic Benefits 22

3 Introduction 23
3.1 GBI Research Report Guidance 24

4 Diabetes – Disease Overview 25
4.1 Types of Diabetes 25
4.1.1 Type 1 Diabetes 25
4.1.2 Type 2 Diabetes 25
4.1.3 Gestational Diabetes 25
4.1.4 Signs and Symptoms 26
4.1.5 Diabetes Diagnosis 26

5 Diabetes – Epidemiology 28

6 Global Insulin Delivery Devices Market: Device Overview 29
6.1 Insulin Pen 29
6.1.1 Reusable Pen 29
6.1.2 Disposable Pen 29
6.1.3 Pen Needle 30
6.2 Insulin Pump 30
6.2.1 Traditional Insulin Pump 30
6.2.2 Disposable Insulin Pump 30
6.3 Insulin Syringe 30
6.4 Traditional Insulin Pump Accessories 30
6.5 Comparison of Insulin Delivery Devices 31

7 Global Insulin Delivery Devices Market: Market Characterization 32
7.1 Global Insulin Delivery Devices Market, Revenue ($bn), 2005–2012 32
7.2 Global Insulin Delivery Devices Market, Revenue, 2012–2019 33
7.3 Insulin Delivery Devices Market, Global, Key Company Shares, 2012 35
7.3.1 Global 37
7.3.2 North America 37
7.3.3 Europe 38
7.3.4 Asia-Pacific 38
7.4 Insulin Delivery Devices Market, Key Trends 39
7.4.1 Companies Move Closer to Developing Fully Automated Artificial Pancreas System 39
7.4.2 Collaborations Foster Innovation in Insulin Delivery Devices Market 42
7.4.3 Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System 44
7.5 Market Dynamics 44
7.5.1 Market Drivers 45
7.5.2 Market Restraints 55

8 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 56
8.1 Insulin Pens Market, Global, Revenue, 2005–2012 56
8.2 Insulin Pens Market, Global, Revenue, 2012–2019 57
8.3 Insulin Pumps Market, Global, Revenue, 2005–2012 59
8.4 Insulin Pumps Market, Global, Revenue, 2012–2019 61
8.5 Insulin Syringes Market, Global, Revenue, 2005–2012 63
8.6 Insulin Syringes Market, Global, Revenue, 2012–2019 65
8.7 Traditional Insulin Pump Accessories Market, Global, Revenue, 2005–2012 66
8.8 Traditional Insulin Pump Accessories Market, Global, Revenue, 2012–2019 68

9 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 70
9.1 Insulin Delivery Devices Market: Cross-country Analysis 70
9.2 Historic and Forecast Revenue and Volume, by Country 72
9.2.1 Insulin Delivery Devices Market, US, Revenue and Volume, 2005–2019 72
9.2.2 Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005–2019 75
9.2.3 Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005–2019 79
9.2.4 Insulin Delivery Devices Market, France, Revenue, 2005–2012 83
9.2.5 Insulin Delivery Devices Market, UK, Revenue and Volume, 2005–2019 86
9.2.6 Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005–2019 89
9.2.7 Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005–2019 92
9.2.8 Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005–2019 95
9.2.9 Insulin Delivery Devices Market, China, Revenue, Volume, 2005–2019 98
9.2.10 Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005–2019 101
9.2.11 Insulin Delivery Devices Market, India, Revenue, 2005–2012 104
9.2.12 Insulin Delivery Devices Market, Brazil, Revenue, 2005–2019 107

10 Global Insulin Delivery Devices Market: Reimbursement System 111
10.1 US 111
10.2 Europe 111
10.2.1 Germany 111
10.2.2 France 111
10.2.3 Italy 111
10.2.4 Spain 111
10.2.5 UK 112
10.2.6 Denmark 112
10.2.7 Norway 112
10.2.8 Sweden 112
10.2.9 Belgium 112
10.2.10 Netherlands 113
10.2.11 Luxembourg 113
10.3 Asia-Pacific 113

11 Global Insulin Delivery Devices Market: Competitive Landscape 114
11.1 Comparison of Leading Insulin Pumps by Size and Color Options, 2014 114
11.2 Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 115
11.3 Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 116
11.4 Novo Nordisk (Subsidiary of Novo A/S) 117
11.4.1 Business Overview 117
11.4.2 Marketed Products 118
11.5 Sanofi 118
11.5.1 Business Overview 118
11.5.2 Marketed Products 118
11.6 Eli Lilly 119
11.6.1 Business Overview 119
11.6.2 Marketed Products 119
11.7 Medtronic 119
11.7.1 Business Overview 119
11.7.2 Marketed Products 120
11.8 Becton, Dickinson and Company 120
11.8.1 Business Overview 120
11.8.2 Marketed Products 121
11.9 Animas 121
11.9.1 Business Overview 121
11.9.2 Marketed Products 121
11.10 F. Hoffmann-La Roche 122
11.10.1 Business Overview 122
11.10.2 Marketed Products 122
11.11 Insulet 122
11.11.1 Business Overview 122
11.11.2 Marketed Products 123
11.12 Asante Solutions 123
11.12.1 Business Overview 123
11.13 Abbott Laboratories 123
11.13.1 Business Overview 123
11.13.2 Marketed Products 124
11.14 Ypsomed 124
11.14.1 Business Overview 124
11.14.2 Marketed Products 125
11.15 Owen Mumford 125
11.15.1 Business Overview 125
11.15.2 Marketed Products 125
11.16 Bioject Medical Technologies 125
11.16.1 Business Overview 125
11.16.2 Marketed Products 126
11.17 Injex - Equidyne Systems 126
11.17.1 Business Overview 126
11.17.2 Marketed Products 126
11.18 Antares Pharma 127
11.18.1 Business Overview 127
11.18.2 Marketed Products 127
11.19 Tandem Diabetes Care 128
11.19.1 Business Overview 128
11.19.2 Marketed Products 128
11.20 Tonghua Dongbao Pharmaceutical 128
11.20.1 Business Overview 128
11.20.2 Marketed Products 129
11.21 Shanghai Fosun Pharmaceutical 129
11.21.1 Business Overview 129
11.21.2 Marketed Products 129

12 Global Insulin Delivery Devices Market: Product Pipeline Analysis 130
12.1 Insulin Delivery Devices Market: List of Pipeline Products 131
12.1.1 Insulin Pumps, List of Pipeline Products 131
12.1.2 Insulin Pens, List of Pipeline Products 132
12.2 Insulin Delivery Devices Market: Profiles of Key Pipeline Products 132
12.2.1 5th Generation CGM Sensor with t:slim Insulin Delivery System 132
12.2.2 Accu-Chek Insight 133
12.2.3 Angel Touch 133
12.2.4 Animas Vibe Insulin Pump and CGM System 134
12.2.5 Bolus Patch 134
12.2.6 Cellnovo Wireless Insulin Pump System 135
12.2.7 Freehand Patch Pump 136
12.2.8 Insulin Pump 136
12.2.9 InsuPatch Device 138
12.2.10 Integrated CGM with Next Gen OmniPod System PDM 138
12.2.11 Jewel Pump 138
12.2.12 La Fenice E 139
12.2.13 La Fenice V 140
12.2.14 Lanzi 140
12.2.15 Mini Pump 141
12.2.16 MiniMed 640G 141
12.2.17 MinIn 142
12.2.18 OmniPod Insulin Pump – New Version 142
12.2.19 Onetouch Ping Verio Insulin Pump with Meter Remote 143
12.2.20 OneTouch with Next Gen Omnipod 143
12.2.21 Patch Pump 1 144
12.2.22 Patch Pump 2 144
12.2.23 Patch Pump 3 145
12.2.24 Spring Insulin Pump 145
12.2.25 Spring Zone Hybrid Patch Pump 145
12.2.26 U-Strip Insulin Patch 146
12.2.27 Exenatide Once Weekly Pen Device 146
12.2.28 Fix-Flex Device 147
12.2.29 G-Pen 147
12.2.30 G-Pen Mini 147
12.2.31 Insulin Guard Self-Injector Safety Needle 148
12.2.32 JuniorSTAR 148
12.2.33 La Fenice Pen 149
12.2.34 Levemir FlexTouch 149
12.2.35 Next Generation Pen Needle II 150
12.2.36 NovoLog FlexTouch 150

13 Global Insulin Delivery Devices Market: Consolidation Landscape 151
13.1 Deals Summary (2004–2013) 151
13.2 Key Deals (2009–2013) 152
13.2.1 LifeScan Acquires Calibra Medical 152
13.2.2 Roche Holding Acquires Medingo from Elron Electronic Industries, 2010 152
13.2.3 Insulet Enters into Co-Development Agreement with Eli Lilly, 2013 152
13.2.4 Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013 153
13.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012 153
13.2.6 Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012 154
13.2.7 Insulet Expands Distribution Agreement with Ypsomed Holding, 2012 154

14 Appendix 156
14.1 Definitions 156
14.1.1 Insulin Delivery 156
14.2 Abbreviations 157
14.3 Bibliography 158
14.4 Research Methodology 161
14.4.1 Secondary Research 161
14.4.2 Primary Research 162
14.4.3 Models 162
14.4.4 Forecasts 163
14.4.5 Expert Panel 163
14.5 Contact Us 163
14.6 Disclaimer 163

List of Tables


Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013 28
Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012 32
Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019 34
Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 36
Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035 47
Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013 48
Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005–2012 57
Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019 58
Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005–2012 60
Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012–2019 62
Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005–2012 64
Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019 66
Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012 67
Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019 69
Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019 70
Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2012 74
Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012–2019 74
Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume (‘000), 2005–2012 78
Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume (‘000), 2012–2019 78
Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2005–2012 82
Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2012–2019 82
Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2005–2012 85
Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2012–2019 85
Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2005–2012 88
Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2012–2019 88
Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2005–2012 91
Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2012–2019 91
Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2005–2012 94
Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2012–2019 94
Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2005–2012 97
Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2012–2019 97
Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2005–2012 100
Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2012–2019 100
Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2005–2012 103
Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2012–2019 103
Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘000), 2005–2012 106
Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘000), 2012–2019 106
Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2005–2012 109
Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2012–2019 109
Table 40: Novo Nordisk, Key Marketed Products, 2013 118
Table 41: Sanofi, Key Marketed Products, 2013 118
Table 42: Eli Lilly, Key Marketed Products, 2013 119
Table 43: Abbott Laboratories, Key Marketed Products, 2013 120
Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013 121
Table 45: Animas, Key Marketed Products, 2013 121
Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013 122
Table 47: Insulet, Key Marketed Products, 2013 123
Table 48: Asante Solutions, Key Marketed Products, 2013 123
Table 49: Abbott Laboratories, Key Marketed Products, 2013 124
Table 50: Ypsomed Holding AG, Key Marketed Products, 2013 125
Table 51: Owen Mumford, Key Marketed Products, 2014 125
Table 52: Bioject Medical Technologies, Key Marketed Products, 2014 126
Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014 127
Table 54: Antares Pharma, Key Marketed Products, 2014 128
Table 55: Tandem Diabetes Care, Key Marketed Products, 2014 128
Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014 129
Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014 129
Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014 131
Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014 132
Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014 133
Table 61: Accu-Chek Insight, Product Status, 2014 133
Table 62: Angel Touch, Product Status, 2014 134
Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014 134
Table 64: Bolus Patch, Product Status, 2014 135
Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014 136
Table 66: Freehand Patch Pump, Product Status, 2014 136
Table 67: Insulin Pump, Product Status, 2014 137
Table 68: InsuPatch Device, Product Status, 2014 138
Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014 138
Table 70: Jewel Pump, Product Status, 2014 139
Table 71: La Fenice E, Product Status, 2014 140
Table 72: La Fenice V, Product Status, 2014 140
Table 73: Lanzi, Product Status, 2014 141
Table 74: Mini Pump, Product Status, 2014 141
Table 75: MiniMed 640G, Product Status, 2014 142
Table 76: MinIn, Product Status, 2014 142
Table 77: OmniPod Insulin Pump – New Version, Product Status, 2014 143
Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014 143
Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014 144
Table 80: Patch Pump 1, Product Status, 2014 144
Table 81: Patch Pump 2, Product Status, 2014 145
Table 82: Patch Pump 3, Product Status, 2014 145
Table 83: Spring Insulin Pump, Product Status, 2014 145
Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014 146
Table 85: U-Strip Insulin Patch, Product Status, 2014 146
Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014 147
Table 87: Fix-Flex Device, Product Status, 2014 147
Table 88: G-Pen, Product Status, 2014 147
Table 89: G-Pen Mini, Product Status, 2014 148
Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014 148
Table 91: JuniorSTAR, Product Status, 2014 149
Table 92: La Fenice Pen, Product Status, 2014 149
Table 93: Levemir FlexTouch, Product Status, 2014 150
Table 94: Next Generation Pen Needle II, Product Status, 2014 150
Table 95: NovoLog FlexTouch, Product Status, 2014 151

List of Figures


Figure 1: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019 15
Figure 2: Insulin Pumps Market, US, Key Company Shares (%), Key Geography Share (%), 2012 17
Figure 3: Diabetes Prevalence by International Diabetes Federation Regions (million), 2013 18
Figure 4: Insulin Delivery Devices Market, Cross-segment Analysis by Region, CAGR (%), 2005–2019 20
Figure 5: Insulin Delivery Devices Market, Artificial Pancreas System, Key Attributes, 2014 21
Figure 6: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963–2011 23
Figure 7: Insulin Delivery Devices Market, Device Overview 29
Figure 8: Insulin Delivery Devices Market, Comparison of Insulin Therapy 31
Figure 9: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012 32
Figure 10: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019 34
Figure 11: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 36
Figure 12: Insulin Delivery Devices Market, Market Trends 39
Figure 13: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas 40
Figure 14: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013 42
Figure 15: Insulin Delivery Devices Market, Market Dynamics 45
Figure 16: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035 46
Figure 17: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013 48
Figure 18: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps 50
Figure 19: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032 52
Figure 20: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes 53
Figure 21: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes 54
Figure 22: Insulin Pens Market, Global, Revenue ($bn), 2005–2012 56
Figure 23: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019 58
Figure 24: Insulin Pumps Market, Global, Revenue ($m), 2005–2012 60
Figure 25: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012–2019 62
Figure 26: Insulin Syringes Market, Global, Revenue ($m), 2005–2012 64
Figure 27: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019 65
Figure 28: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012 67
Figure 29: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019 68
Figure 30: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019 70
Figure 31: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005–2019 72
Figure 32: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2019 73
Figure 33: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005–2019 76
Figure 34: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005–2019 77
Figure 35: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005–2019 80
Figure 36: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2005–2019 81
Figure 37: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005–2019 83
Figure 38: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2005–2019 84
Figure 39: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005–2019 86
Figure 40: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2005–2019 87
Figure 41: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005–2019 89
Figure 42: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2005–2019 90
Figure 43: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005–2019 92
Figure 44: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2005–2019 93
Figure 45: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005–2019 95
Figure 46: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2005–2019 96
Figure 47: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005–2019 98
Figure 48: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2005–2019 99
Figure 49: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005–2019 101
Figure 50: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2005–2019 102
Figure 51: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005–2019 104
Figure 52: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘0000), 2005–2019 105
Figure 53: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005–2019 107
Figure 54: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2005–2019 108
Figure 55: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014 114
Figure 56: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 115
Figure 57: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 116
Figure 58: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013 130
Figure 59: Global Insulin Delivery Devices Market, Deals Summary, 2013 151

Upcoming Reports:

IV Therapy and Vein Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The global market for intravenous and vein access devices encompasses a variety of devices such as peripheral venous access, central venous access, ambulatory infusion, enteral feeding, syringe infusion, implantable pumps and diabetes insulin infusion devices. These devices are used for intravenous administration of drugs, fluid infusion, blood sampling, venous pressure monitoring, blood and transfusion. Implantable ports, catheters, syringes, needles and needless connectors are examples of various intravenous therapy and vein access devices. Some of the commercially available...
Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
By - Transparency Market Research
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. TB typically infects lungs (Pulmonary tuberculosis) but may also infect other parts of body (Extrapulmonary tuberculosis) such as central nervous system, lymphatic system and genitourinary system. Symptoms of the disease are fever, night sweat, chronic cough, blood-tinged sputum. According to a data published by World Health Organization (WHO), in 2012 around 8.6 million people were diagnosed with tuberculosis while 1.3 million died with the disease. Various Multi Drug Resistant (MDR) forms of the...
Cryogenic Equipment Market - Global And China Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Cryogenic equipments are designed to keep liquefied gases in liquid state as these gases are required to be stored at a temperature below -150°C, commonly referred as cryogenic temperature. Some of the major factors driving this market are the increasing consumption and demand of energy and power from the growing population and industrialization. With the growth in global economy, especially china the demand for cryogenic equipments is set to rise. Cryogenic equipments are widely used in industries such as chemical, electronic, metals, energy, and power among others. Among all the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

OnePlus One ready to launch it smart phone in India
Jul 28, 2014  
Chinese smart phones are gaining popularity in the Indian market. OnePlus, a Chinese smart phones company, is ready to launch the invitation-only One smart phone in India.  Many Chinese smart phone brands have got inspired by the success of another smart phone brand called Xiaomi which had successfully launched the Mi 3, a smart phone in the Indian market. The OnePlus One is a typical...
Danone all set to sell its business to Hospira
Jul 28, 2014  
According to the Financial Times, Danone, a French dairy group is aiming at selling its business pertaining to medical nutrition to Hospira, a US group. The deal value is estimated at $ 5 billion.  The plan is still in the pipeline as nothing with respect to the business is fully confirmed or certain. Representatives of neither business groups were willing to comment on the same. ...
At a USD 62 Price Tag, the Karbonn A50S Smartphone Could Challenge Likes of Apple and Samsung in India
Jul 28, 2014  
A USD 62 smartphone launched in the Indian market by Karbonn could signal stiff competition for behemoths such as Apple that makes the iPhone and Samsung, known best for its Galaxy smartphone range. The Karbonn A50S, which has been officially launched in India, can also be ordered by customers outside of the country via online stores, and delivered to their doorstep. Given its exceptionally...
Tablet overall sales up 11% in Q2; Lenovo, Asus big gainers
Jul 28, 2014  
The sale of tablets in the second quarter of 2014 went up 11% from a year ago, selling 49.3 million devices. However, the number is 1.5% lower than that from the previous quarter. A survey conducted by IDC, a market research firm, suggests that while the overall sales went up, Apple and Samsung both lost market share in the March-June period. However, the sales were boosted largely by...
Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...